Meetings and ConferencesBehrouz Mansouri Taleghani, on behalf of the Board of the German Society of Transfusion Medicine and Immunohaematology, Hans‐Gert Heuft et al.|Transfusion Medicine and Hemotherapy|2014Cited by 0
Trial in progress: A study of roginolisib in combination with ruxolitinib in patients with myelofibrosis who are unresponsive to JAK inhibitors (HEMA-MED)Alessandro M. Vannucchi, Matteo Della Porta, Giusy Di Conza et al.|Blood|2025Cited by 0